3D Systems Co. (NYSE:DDD) Given Average Recommendation of “Hold” by Analysts

3D Systems Co. (NYSE:DDD) has been assigned an average rating of “Hold” from the twelve brokerages that are currently covering the company, …

3D Systems logo3D Systems Co. (NYSE:DDD) has been assigned an average rating of “Hold” from the twelve brokerages that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $11.56.

A number of research analysts recently commented on DDD shares. Craig Hallum set a $23.00 target price on Sientra and gave the company a “buy” rating in a research note on Monday, April 22nd. ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. Zacks Investment Research upgraded shares of Gerdau from a “sell” rating to a “hold” rating in a research report on Monday, May 13th. JPMorgan Chase & Co. set a €52.00 ($60.47) price target on shares of Vonovia and gave the company a “buy” rating in a research report on Friday, May 10th. Finally, Piper Jaffray Companies cut their price target on shares of Apyx Medical to $7.00 and set an “overweight” rating for the company in a research report on Wednesday, May 8th.

In other 3D Systems news, insider Vyomesh Joshi purchased 29,920 shares of the business’s stock in a transaction on Monday, May 13th. The stock was acquired at an average cost of $8.22 per share, for a total transaction of $245,942.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 3.30% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of DDD. CWM Advisors LLC increased its position in shares of 3D Systems by 32.0% during the second quarter. CWM Advisors LLC now owns 23,497 shares of the 3D printing company’s stock valued at $214,000 after acquiring an additional 5,699 shares in the last quarter. Exane Derivatives bought a new stake in shares of 3D Systems during the second quarter valued at approximately $216,000. Formula Growth Ltd. bought a new stake in shares of 3D Systems during the first quarter valued at approximately $4,204,000. GMT Capital Corp bought a new stake in shares of 3D Systems during the first quarter valued at approximately $2,596,000. Finally, ARK Investment Management LLC boosted its holdings in 3D Systems by 29.5% in the first quarter. ARK Investment Management LLC now owns 178,320 shares of the 3D printing company’s stock worth $1,919,000 after purchasing an additional 40,595 shares during the last quarter. Institutional investors and hedge funds own 70.42% of the company’s stock.

DDD opened at $8.77 on Friday. The company has a market capitalization of $1.03 billion, a PE ratio of -23.70 and a beta of 1.98. The company has a current ratio of 2.56, a quick ratio of 1.78 and a debt-to-equity ratio of 0.17. 3D Systems has a 52 week low of $7.81 and a 52 week high of $21.78. The company has a fifty day moving average price of $8.61.

3D Systems (NYSE:DDD) last released its earnings results on Tuesday, May 7th. The 3D printing company reported ($0.20) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.13). The firm had revenue of $152.00 million during the quarter, compared to the consensus estimate of $164.69 million. 3D Systems had a negative net margin of 7.26% and a negative return on equity of 6.26%. The firm’s revenue was down 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.03) EPS. As a group, equities research analysts predict that 3D Systems will post -0.35 EPS for the current year.

3D Systems Company Profile

3D Systems Corporation, through its subsidiaries, provides three-dimensional (3D) printing products and services worldwide. The company offers 3D printers, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, and color jet printers that transform data input generated by 3D design software, CAD software, or other 3D design tools into printed parts under the Accura, DuraForm, LaserForm, CastForm, and VisiJet brand names.

Read More: How to Use a Moving Average for Trading

Analyst Recommendations for 3D Systems (NYSE:DDD)

Receive News & Ratings for 3D Systems Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 3D Systems and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Ion Asset Management Ltd. Acquires Shares of 60000 Crowdstrike Holdings Inc (NASDAQ:CRWD)

Ion Asset Management Ltd. acquired a new stake in Crowdstrike Holdings Inc (NASDAQ:CRWD) during the second quarter, Holdings Channel.com …

Crowdstrike logoIon Asset Management Ltd. acquired a new stake in Crowdstrike Holdings Inc (NASDAQ:CRWD) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 60,000 shares of the company’s stock, valued at approximately $4,097,000. Crowdstrike comprises 1.0% of Ion Asset Management Ltd.’s investment portfolio, making the stock its 8th biggest position.

Several other hedge funds have also recently added to or reduced their stakes in CRWD. Artemis Investment Management LLP purchased a new position in shares of Crowdstrike during the second quarter valued at about $2,725,000. Commonwealth Equity Services LLC purchased a new position in shares of Crowdstrike during the second quarter valued at about $412,000. Finally, FNY Investment Advisers LLC purchased a new position in shares of Crowdstrike during the second quarter valued at about $302,000. Hedge funds and other institutional investors own 0.13% of the company’s stock.

Several brokerages recently issued reports on CRWD. Stifel Nicolaus boosted their price target on shares of Crowdstrike from $80.00 to $90.00 and gave the company a “buy” rating in a research report on Friday, July 19th. JMP Securities began coverage on shares of Crowdstrike in a research report on Monday, July 8th. They set an “outperform” rating and a $80.00 price target on the stock. Needham & Company LLC boosted their price target on shares of Crowdstrike from $80.00 to $92.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Goldman Sachs Group began coverage on shares of Crowdstrike in a research report on Monday, July 8th. They set a “neutral” rating and a $66.00 price target on the stock. Finally, Royal Bank of Canada began coverage on shares of Crowdstrike in a research report on Monday, July 8th. They set a “sector perform” rating and a $70.00 price target on the stock. Five equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $84.47.

In other Crowdstrike news, major shareholder Capitalg Lp acquired 140,000 shares of the business’s stock in a transaction on Friday, June 14th. The shares were acquired at an average price of $34.00 per share, for a total transaction of $4,760,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Sameer K. Gandhi acquired 650,000 shares of the business’s stock in a transaction on Friday, June 14th. The stock was acquired at an average price of $34.00 per share, for a total transaction of $22,100,000.00. The disclosure for this purchase can be found here.

Shares of CRWD opened at $85.48 on Tuesday. Crowdstrike Holdings Inc has a fifty-two week low of $56.00 and a fifty-two week high of $96.19. The business has a 50-day simple moving average of $76.39.

Crowdstrike (NASDAQ:CRWD) last announced its quarterly earnings data on Thursday, July 18th. The company reported ($0.47) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.31) by ($0.16). The business had revenue of $96.10 million for the quarter, compared to analyst estimates of $95.60 million. The business’s revenue was up 103.2% on a year-over-year basis. As a group, equities analysts expect that Crowdstrike Holdings Inc will post -1.07 EPS for the current year.

Further Reading: Trading Ex-Dividend Strategy

Want to see what other hedge funds are holding CRWD?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crowdstrike Holdings Inc (NASDAQ:CRWD).

Institutional Ownership by Quarter for Crowdstrike (NASDAQ:CRWD)

Receive News & Ratings for Crowdstrike Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Crowdstrike and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

DHI Group (NYSE:DHX) Upgraded at TheStreet

Acadian Asset Management LLC grew its stake in DHI Group by 16.2% during the first quarter. Acadian Asset Management LLC now owns 1,211,192 …

DHI Group logoDHI Group (NYSE:DHX) was upgraded by equities research analysts at TheStreet from a “c” rating to a “b-” rating in a research note issued on Friday, TheStreetRatingsTable reports.

A number of other brokerages also recently commented on DHX. ValuEngine downgraded shares of DHI Group from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Zacks Investment Research downgraded shares of DHI Group from a “hold” rating to a “sell” rating in a report on Monday.

Shares of NYSE DHX opened at $3.41 on Friday. The stock has a market capitalization of $190.98 million, a P/E ratio of 22.73, a PEG ratio of 0.71 and a beta of 1.59. DHI Group has a 12 month low of $1.34 and a 12 month high of $4.44. The company has a current ratio of 0.38, a quick ratio of 0.38 and a debt-to-equity ratio of 0.15. The business’s 50-day moving average price is $3.78.

In other news, Director Golnar Sheikholeslami sold 39,200 shares of DHI Group stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $3.94, for a total transaction of $154,448.00. Following the completion of the sale, the director now directly owns 134,750 shares in the company, valued at $530,915. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 8.10% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in DHX. Hillsdale Investment Management Inc. grew its holdings in DHI Group by 5,062.6% in the second quarter. Hillsdale Investment Management Inc. now owns 469,800 shares of the technology company’s stock valued at $1,677,000 after purchasing an additional 460,700 shares during the period. Punch & Associates Investment Management Inc. grew its stake in DHI Group by 76.0% during the first quarter. Punch & Associates Investment Management Inc. now owns 638,100 shares of the technology company’s stock worth $1,551,000 after buying an additional 275,600 shares during the period. Municipal Employees Retirement System of Michigan purchased a new stake in DHI Group during the fourth quarter worth approximately $301,000. Acadian Asset Management LLC grew its stake in DHI Group by 16.2% during the first quarter. Acadian Asset Management LLC now owns 1,211,192 shares of the technology company’s stock worth $2,943,000 after buying an additional 168,638 shares during the period. Finally, Strs Ohio purchased a new stake in DHI Group during the second quarter worth approximately $513,000. Hedge funds and other institutional investors own 62.32% of the company’s stock.

About DHI Group

DHI Group, Inc provides data, insights, and employment connections through specialized services for technology professionals in the United States and internationally. The company operates Dice that offers job postings of technology and non-technology companies for industries, such as positions for software engineers, big data professionals, systems administrators, database specialists, project managers, and other technology and engineering professionals; and ClearanceJobs, an Internet-based career network, which matches security-cleared professionals with hiring companies searching for employees.

Read More: What is a put option?

Receive News & Ratings for DHI Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DHI Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

BTIM Corp. Decreases Stock Holdings in Charles River Laboratories Intl. Inc (NYSE:CRL)

AQR Capital Management LLC lifted its position in shares of Charles River Laboratories Intl. by 18.0% in the 1st quarter. AQR Capital Management …

Charles River Laboratories Intl. logoBTIM Corp. lowered its stake in shares of Charles River Laboratories Intl. Inc (NYSE:CRL) by 1.0% during the second quarter, Holdings Channel reports. The institutional investor owned 143,260 shares of the medical research company’s stock after selling 1,480 shares during the period. BTIM Corp.’s holdings in Charles River Laboratories Intl. were worth $20,328,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in CRL. BlackRock Inc. lifted its position in shares of Charles River Laboratories Intl. by 1.3% in the 1st quarter. BlackRock Inc. now owns 4,587,801 shares of the medical research company’s stock worth $666,379,000 after buying an additional 57,789 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Charles River Laboratories Intl. by 18.0% in the 1st quarter. AQR Capital Management LLC now owns 2,082,761 shares of the medical research company’s stock worth $301,042,000 after buying an additional 317,001 shares during the last quarter. Norges Bank bought a new position in shares of Charles River Laboratories Intl. in the 4th quarter worth about $61,460,000. Geode Capital Management LLC lifted its position in shares of Charles River Laboratories Intl. by 6.7% in the 4th quarter. Geode Capital Management LLC now owns 457,529 shares of the medical research company’s stock worth $51,782,000 after buying an additional 28,878 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Charles River Laboratories Intl. by 16.3% in the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 349,864 shares of the medical research company’s stock worth $50,818,000 after buying an additional 49,035 shares during the last quarter. 94.61% of the stock is currently owned by hedge funds and other institutional investors.

In other news, Director George Massaro sold 3,140 shares of the firm’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $134.64, for a total transaction of $422,769.60. Following the completion of the transaction, the director now owns 15,344 shares in the company, valued at approximately $2,065,916.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider William D. Barbo sold 4,905 shares of the firm’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $125.16, for a total transaction of $613,909.80. Following the transaction, the insider now owns 25,859 shares of the company’s stock, valued at approximately $3,236,512.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 9,047 shares of company stock worth $1,168,322. 1.80% of the stock is owned by corporate insiders.

CRL stock opened at $126.51 on Tuesday. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.38 and a current ratio of 1.59. Charles River Laboratories Intl. Inc has a fifty-two week low of $103.00 and a fifty-two week high of $149.07. The business has a 50-day moving average price of $137.74. The firm has a market cap of $6.50 billion, a PE ratio of 22.00, a PEG ratio of 1.70 and a beta of 1.10.

Charles River Laboratories Intl. (NYSE:CRL) last released its earnings results on Wednesday, July 31st. The medical research company reported $1.63 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.55 by $0.08. The firm had revenue of $657.60 million for the quarter, compared to analysts’ expectations of $662.61 million. Charles River Laboratories Intl. had a net margin of 8.94% and a return on equity of 22.01%. Charles River Laboratories Intl.’s quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter last year, the company earned $1.62 EPS. On average, analysts expect that Charles River Laboratories Intl. Inc will post 6.53 earnings per share for the current fiscal year.

A number of research firms recently weighed in on CRL. ValuEngine cut shares of Charles River Laboratories Intl. from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Zacks Investment Research raised shares of Charles River Laboratories Intl. from a “sell” rating to a “hold” rating and set a $149.00 price objective on the stock in a report on Wednesday, July 31st. Evercore ISI reaffirmed an “outperform” rating and issued a $160.00 price objective on shares of Charles River Laboratories Intl. in a report on Tuesday, April 30th. Leerink Swann began coverage on shares of Charles River Laboratories Intl. in a report on Monday, June 10th. They issued an “outperform” rating on the stock. Finally, Svb Leerink began coverage on shares of Charles River Laboratories Intl. in a report on Monday, June 10th. They issued an “outperform” rating and a $155.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $147.29.

Charles River Laboratories Intl. Profile

Charles River Laboratories International, Inc, an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services worldwide. It operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing).

Featured Story: Balance Sheet

Want to see what other hedge funds are holding CRL?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Charles River Laboratories Intl. Inc (NYSE:CRL).

Institutional Ownership by Quarter for Charles River Laboratories Intl. (NYSE:CRL)

Receive News & Ratings for Charles River Laboratories Intl. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Charles River Laboratories Intl. and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Altium Wealth Management LLC Sells 1064 Shares of BlackRock, Inc. (NYSE:BLK)

Altium Wealth Management LLC reduced its position in shares of BlackRock, Inc. (NYSE:BLK) by 26.5% in the 2nd quarter, according to its most …

BlackRock logoAltium Wealth Management LLC reduced its position in shares of BlackRock, Inc. (NYSE:BLK) by 26.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,958 shares of the asset manager’s stock after selling 1,064 shares during the period. Altium Wealth Management LLC’s holdings in BlackRock were worth $1,388,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Advisory Alpha LLC acquired a new stake in BlackRock during the first quarter worth approximately $26,000. Valley National Advisers Inc. grew its position in BlackRock by 81.8% during the first quarter. Valley National Advisers Inc. now owns 60 shares of the asset manager’s stock worth $26,000 after buying an additional 27 shares in the last quarter. SevenBridge Financial Group LLC acquired a new stake in shares of BlackRock in the 2nd quarter valued at $38,000. Harvest Group Wealth Management LLC acquired a new stake in shares of BlackRock in the 1st quarter valued at $37,000. Finally, Rational Advisors LLC boosted its holdings in shares of BlackRock by 260.0% in the 1st quarter. Rational Advisors LLC now owns 90 shares of the asset manager’s stock valued at $38,000 after purchasing an additional 65 shares in the last quarter. Institutional investors and hedge funds own 81.68% of the company’s stock.

Shares of BlackRock stock opened at $431.32 on Tuesday. The company has a market cap of $69.26 billion, a price-to-earnings ratio of 16.02, a price-to-earnings-growth ratio of 1.66 and a beta of 1.51. The company has a debt-to-equity ratio of 0.83, a current ratio of 3.49 and a quick ratio of 3.49. BlackRock, Inc. has a one year low of $360.79 and a one year high of $494.91. The company has a 50-day moving average price of $469.16.

BlackRock (NYSE:BLK) last released its quarterly earnings results on Friday, July 19th. The asset manager reported $6.41 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.52 by ($0.11). BlackRock had a net margin of 30.25% and a return on equity of 13.23%. The company had revenue of $3.52 billion for the quarter, compared to analyst estimates of $3.57 billion. During the same quarter last year, the firm posted $6.66 EPS. BlackRock’s revenue for the quarter was down 2.2% on a year-over-year basis. On average, sell-side analysts predict that BlackRock, Inc. will post 27.62 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Thursday, September 5th will be paid a $3.30 dividend. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $13.20 dividend on an annualized basis and a dividend yield of 3.06%. BlackRock’s payout ratio is presently 49.02%.

A number of equities research analysts have weighed in on BLK shares. JPMorgan Chase & Co. reduced their target price on BlackRock from $527.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, July 22nd. Citigroup raised their price objective on BlackRock from $450.00 to $500.00 and gave the company a “buy” rating in a report on Monday, April 15th. Wells Fargo & Co raised their price objective on BlackRock from $460.00 to $480.00 and gave the company an “average” rating in a report on Wednesday, April 17th. Morgan Stanley raised their target price on BlackRock from $550.00 to $553.00 and gave the stock an “overweight” rating in a research report on Monday, July 22nd. Finally, UBS Group raised their target price on BlackRock from $515.00 to $525.00 and gave the stock a “buy” rating in a research report on Monday, July 8th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $499.03.

BlackRock Profile

BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Featured Article: Understanding debt-to-equity ratio in fundamental analysis

Institutional Ownership by Quarter for BlackRock (NYSE:BLK)

Receive News & Ratings for BlackRock Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts